Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation

…, R Loginov, H Kallio-Kokko, O Vapalahti, H Jarva… - Journal of Clinical …, 2020 - Elsevier
There is an urgent need for reliable high-throughput serological assays for the management
of the ongoing COVID-19 pandemic. Preferably, the performance of serological tests for a …

Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein

M Laine, H Jarva, S Seitsonen… - The Journal of …, 2007 - journals.aai.org
Complement factor H (FH) is an important regulator of the alternative complement pathway.
The Y402H polymorphism within the seventh short consensus repeat of FH was recently …

Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat …

H Jarva, TS Jokiranta, J Hellwage… - The Journal of …, 1999 - journals.aai.org
C-reactive protein (CRP) is a major acute phase protein whose functions are not totally clear.
In this study, we examined the interaction of CRP with factor H (FH), a key regulator of the …

Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation

L Deban, H Jarva, MJ Lehtinen, B Bottazzi… - The Journal of …, 2008 - journals.aai.org
The long pentraxin PTX3 is a multifunctional soluble molecule involved in inflammation and
innate immunity. As an acute phase protein, PTX3 binds to the classical pathway …

Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus …

H Jarva, R Janulczyk, J Hellwage, PF Zipfel… - The Journal of …, 2002 - journals.aai.org
Streptococcus pneumoniae is an important cause of upper and lower respiratory tract
infections, meningitis, peritonitis, bacterial arthritis, and sepsis. Here we have studied a novel …

[HTML][HTML] Yersinia enterocolitica Serum Resistance Proteins YadA and Ail Bind the Complement Regulator C4b-Binding Protein

V Kirjavainen, H Jarva, M Biedzka-Sarek… - PLoS …, 2008 - journals.plos.org
Many pathogens are equipped with factors providing resistance against the bactericidal
action of complement. Yersinia enterocolitica, a Gram-negative enteric pathogen with invasive …

[HTML][HTML] Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients

…, O Vapalahti, M Lappalainen, HR Kreivi, H Jarva… - PloS one, 2021 - journals.plos.org
Background Understanding the false negative rates of SARS-CoV-2 RT-PCR testing is
pivotal for the management of the COVID-19 pandemic and it has implications for patient …

[HTML][HTML] Ascitic complement system in ovarian cancer

L Bjørge, J Hakulinen, OK Vintermyr, H Jarva… - British journal of …, 2005 - nature.com
Ovarian cancer spreads intraperitoneally and forms fluid, whereby the diagnosis and therapy
often become delayed. As the complement (C) system may provide a cytotoxic effector arm …

Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis

H Jarva, S Ram, U Vogel, AM Blom… - The Journal of …, 2005 - journals.aai.org
Neisseria meningitidis (meningococcus) is an important cause of meningitis and sepsis.
Currently, there is no effective vaccine against serogroup B meningococcal infection. Host …

Complement resistance mechanisms of streptococci

H Jarva, TS Jokiranta, R Würzner, S Meri - Molecular immunology, 2003 - Elsevier
Group A streptococcus (GAS, Streptococcus pyogenes), group B streptococcus (GBS,
Streptococcus agalactiae) and pneumococcus (Streptococcus pneumoniae) are all human …